Advances in Radiation Oncology of Lung Cancer

Part of the Medical Radiology book series (MEDRAD)


A variety of advanced radiation technologies are currently available that have changed the way we practice Radiation Oncology. In this chapter, the authors will review one such technology, Helical tomotherapy. Basic operations and planning, applications in stereotactic body radiotherapy, and locally advanced lung cancer, as well as developing and future applications in hippocampal sparing whole brain radiation, adaptive radiation, and theragnostic radiation delivery will also be discussed.


Planning Target Volume Intensity Modulate Radiation Therapy Stereotactic Body Radiotherapy Whole Brain Radiation Therapy Helical Tomotherapy 


  1. Adkison JB, Khuntia D et al (2008) Dose escalated, hypofractionated radiotherapy using helical tomotherapy for inoperable non-small cell lung cancer: preliminary results of a risk-stratified phase I dose escalation study. Technol Cancer Res Treat 7(6):441–447PubMedGoogle Scholar
  2. Aoyama H, Tago M et al (2007) Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone. Int J Radiat Oncol Biol Phys 68(5):1388–1395PubMedCrossRefGoogle Scholar
  3. Belderbos JS, Heemsbergen WD et al (2006) Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66(1):126–134PubMedCrossRefGoogle Scholar
  4. Bentzen SM, Gregoire V (2011) Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol 21(2):101–110PubMedCrossRefGoogle Scholar
  5. Chang EL, Wefel JS et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037–1044PubMedCrossRefGoogle Scholar
  6. Chi A, Jang SY et al (2011) Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage nonsmall-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys Jan 19 (Epub ahead of print).Google Scholar
  7. Dawson LA, Jaffray DA (2007) Advances in image-guided radiation therapy. J Clin Oncol Official J Am Soc Clin Oncol 25(8):938–946CrossRefGoogle Scholar
  8. DeAngelis LM, Delattre JY et al (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39(6):789–796PubMedCrossRefGoogle Scholar
  9. Gondi V, Tolakanahalli R et al (2010a) Hippocampal-sparing whole-brain radiotherapy: a “how-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 78(4):1244–1252PubMedCrossRefGoogle Scholar
  10. Gondi V, Tome WA et al (2010b) Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy: safety profile for RTOG 0933. Radiother Oncol J Eur Soc Therap Radiol Oncol 95(3):327–331CrossRefGoogle Scholar
  11. Hodge W, Tome WA et al (2006) Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol 45(7):890–896PubMedCrossRefGoogle Scholar
  12. Khuntia D, Brown P et al (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol Official J Am Soc Clin Oncol 24(8):1295–1304CrossRefGoogle Scholar
  13. Kong FM, Ten Haken RK et al (2005) High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63(2):324–333PubMedCrossRefGoogle Scholar
  14. Mackie TR, Balog J et al (1999) Tomotherapy. Semin Radiat Oncol 9(1):108–117PubMedCrossRefGoogle Scholar
  15. Mackie TR, Kapatoes J et al (2003) Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 56(1):89–105PubMedCrossRefGoogle Scholar
  16. Mehta M, Scrimger R et al (2001) A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 49(1):23–33PubMedCrossRefGoogle Scholar
  17. Mizumatsu S, Monje ML et al (2003) Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res 63(14):4021–4027PubMedGoogle Scholar
  18. Monje ML, Mizumatsu S et al (2002) Irradiation induces neural precursor-cell dysfunction. Nat Med 8(9):955–962PubMedCrossRefGoogle Scholar
  19. Monje ML, Toda H et al (2003) Inflammatory blockade restores adult hippocampal neurogenesis. Science 302(5651):1760–1765PubMedCrossRefGoogle Scholar
  20. Nagata Y, Takayama K et al (2005) Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63(5):1427–1431PubMedCrossRefGoogle Scholar
  21. Perez CA, Stanley K et al (1980) A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group. Cancer 45(11):2744–2753PubMedCrossRefGoogle Scholar
  22. Schubert LK, Westerly DC et al (2009) A comprehensive assessment by tumor site of patient setup using daily MVCT imaging from more than 3, 800 helical tomotherapy treatments. Int J Radiat Oncol Biol Phys 73(4):1260–1269PubMedCrossRefGoogle Scholar
  23. Shah AP, Langen KM et al (2008) Patient dose from megavoltage computed tomography imaging. Int J Radiat Oncol Biol Phys 70(5):1579–1587PubMedCrossRefGoogle Scholar
  24. Siker ML, Tome WA et al (2006) Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? Int J Radiat Oncol Biol Phys 66(1):135–141PubMedCrossRefGoogle Scholar
  25. Song CH, Pyo H et al (2010) Treatment-related pneumonitis and acute esophagitis in non-small-cell lung cancer patients treated with chemotherapy and helical tomotherapy. Int J Radiat Oncol Biol Phys 78(3):651–658PubMedCrossRefGoogle Scholar
  26. Timmerman R, McGarry R et al (2006) Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol Official J Am Soc Clin Oncol 24(30):4833–4839CrossRefGoogle Scholar
  27. Yoon SM, Choi EK et al (2006) Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 45(8):1108–1114PubMedCrossRefGoogle Scholar
  28. Yuan S, Sun X et al (2007) A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Am J Clin Oncol 30(3):239–244PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Western Radiation OncologyMountain ViewUSA
  2. 2.Northwestern UniversityChicagoUSA

Personalised recommendations